Identification of LOF events, such as inactivating gene rearrangements of NOTCH1 and MAML2 support their tumor-suppressive roles in NPC, similar to that described in other head and neck cancers (Supplementary figure 13)32. The gene discussed is MAML2; the disease is head and neck cancer.